<qa>  What is the current basis for Hepatitis B prevention in non-responders uraHepatitis B prevention in non-responders uraemic patients is currently based on both HBsAg surveillance and the isolation from HBsAg carriers. A more immunogenic vaccine would be a benefit for this population. 